Home
/
Immuneering Corp
/
Financials
/
Quarterly
Immuneering Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Immuneering Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$0
Nov 9, 2023
Q2
2023
Jun 30, 2023
$0
Aug 3, 2023
Q1
2023
Mar 31, 2023
$0
May 4, 2023
Q3
2023
Sep 30, 2022
$38.4K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$94.4K
Aug 3, 2023
Q1
2023
Mar 31, 2022
$183.7K
May 4, 2023
Q3
2022
Sep 30, 2021
$482.1K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$660.0K
Aug 10, 2022
Q1
2022
Mar 31, 2021
$748.2K
May 10, 2022
Q3
2021
Sep 30, 2020
$682.6K
Nov 9, 2021
Q2
2021
Jun 30, 2020
$480.8K
Sep 9, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.96M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($14.43M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($14.43M)
Aug 13, 2025
Q3
2025
Mar 31, 2025
($15.05M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($15.05M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($15.05M)
May 5, 2025
Q3
2025
Sep 30, 2024
($14.60M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($14.08M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($14.08M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($14.31M)
May 5, 2025
Q2
2025
Mar 31, 2024
($14.31M)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($14.31M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($12.60M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($12.19M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($12.19M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($13.60M)
May 7, 2024
Q2
2024
Mar 31, 2023
($13.60M)
Aug 6, 2024
Q3
2024
Mar 31, 2023
($13.60M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($12.84M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($11.53M)
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.38M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($14.76M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($15.48M)
May 5, 2025
Q3
2025
Sep 30, 2024
($15.27M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($14.91M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($15.33M)
May 5, 2025
Q3
2024
Sep 30, 2023
($13.93M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($13.50M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($14.68M)
May 7, 2024
Q3
2023
Sep 30, 2022
($13.19M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($11.65M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($12.93M)
May 4, 2023
Q3
2022
Sep 30, 2021
($8.54M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($7.99M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($6.24M)
May 10, 2022
Q3
2021
Sep 30, 2020
($4.40M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($3.61M)
Sep 9, 2021